HomepageEarnings Events Newsdesk 11 hours ago Lantheus Holdings, Inc (LNTH) Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA® Lantheus Holdings, Inc (NASDAQ: LNTH) FY 2026 Other Release Jack Henry & Associates Inc (JKHY) Morgan Stanley Technology, Media & Telecom Conference » « AbbVie (ABBV) AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn's Disease Newsdesk: